Stool Glial Fibrillary Acidic Protein Is Elevated in Progressive Multiple Sclerosis
These exploratory data indicate an altered enteric glial phenotype in patients with ProgMS and suggest that st-GFAP may be a prognostic biomarker.
Authors
- Bonnie I. Glanz (ORCID: https://orcid.org/0000-0002-4344-3456)
- Laura M. Cox (ORCID: https://orcid.org/0000-0002-9564-9894)
- Massimo Filippi (ORCID: https://orcid.org/0000-0002-5485-0479)
- Martina Antonini Cencicchio
- Federico Montini (ORCID: https://orcid.org/0000-0002-8367-0741)
- Tanuja Chitnis (ORCID: https://orcid.org/0000-0002-9897-4422)
- Howard L. Weiner (ORCID: https://orcid.org/0000-0003-0203-9681)
- Marika Falcone (ORCID: https://orcid.org/0000-0001-6080-5351)
- Luke A. Schwerdtfeger (ORCID: https://orcid.org/0000-0001-8030-3164)
- Jonathan R Christenson
Institutions
- Brigham and Women's Hospital (US)
- Vita-Salute San Raffaele University (IT)
- IRCCS Ospedale San Raffaele (IT)
Publication Details
- Journal
- Neurology Neuroimmunology & Neuroinflammation
- Published
- 2025-08-28
- DOI
- https://doi.org/10.1212/nxi.0000000000200466
- Citations
- 1
- Primary Topic
- Neurological diseases and metabolism
- Type
- article
- Field-Weighted Citation Impact
- 0.84